NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OverT Bio

OverT Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://overt.bio/

Last Round

Grant

Nov 22, 2024

Total Funding Raised

$16.12M

Company Overview

OverT Bio is a biotechnology company that develops cell therapies for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

cell therapysolid tumor treatmentoncologyAI-powered drug discoveryengineered T cellsovarian cancer therapybiotech R&Dclinical developmentAI drug discoverynext-gen cell therapyin silico drug discoverybiopharma collaborationAI-native biotechphenotype-driven ML

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OverT Bio Comparables

Compare OverT Bio with similar companies based on industry and business-model similarity.

OverT Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ArsenalBio
82%
Encelta AG
78%
Acepodia
77%

OverT Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 22, 2024
SeedMay 6, 2024

Key People

Founding team and executive leadership

Mat Legut

Co-founder And CEO

Founding Team

Precious Enebeli

Chief Financial Officer

Executive Team

OverT Bio Investors

Notable investors and investment history

OverT Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OverT Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OverT Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range13
Year Founded2022
Last FundingNov 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.